chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Fall, Feeling hot, Full blood count, Hyperhidrosis
Clinical narrative: I was perfectly healthy when I arrived at the pharmacy with my wife. I recieved my Pfizer covid shot and sat down on the chair in the observation waiting area. I felt a light tingling sensation in my arm (in which I got the shot)  but didn't think much of it (as I assumed the vaccine is stored at sub zero temperature). I started using my phone while waiting for my wife to get her shot next.  About 5 mins has elapsed,  that I fell off my chair.  My wife was there and panicked. As described to me by wife (who observed me first hand)  my face turned green as I fell face down from my chair.  My body was having jerky movements (involuntary spasms), I had passed out,  my body temperature was rising, I lost control of my bladder also (it was basically all the manifestations of a seizure). The pharmacist panicked and have me an EPIPEN injection in my thigh (thinking I'm having an allergic reaction). They had also called 911 in the meanwhile. An ambulance arrived and took me to the ER. There they only did an ECG which was normal. They did not preform any blood tests and released me saying that it was "vasovagal syncope". However I spoke with a few family doctors to get opinions and multiple told me that is all signs of a seizure & not syncope. The ER doctor did tell me to make a follow up general checkup appointment with a PCP which I did a couple of weeks later.  The PCP requested a full blood palette test which came out normal.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypersensitivity, Loss of consciousness, Muscle spasms, Paraesthesia, Seizure like phenomena
Clinical narrative: I was perfectly healthy when I arrived at the pharmacy with my wife. I recieved my Pfizer covid shot and sat down on the chair in the observation waiting area. I felt a light tingling sensation in my arm (in which I got the shot)  but didn't think much of it (as I assumed the vaccine is stored at sub zero temperature). I started using my phone while waiting for my wife to get her shot next.  About 5 mins has elapsed,  that I fell off my chair.  My wife was there and panicked. As described to me by wife (who observed me first hand)  my face turned green as I fell face down from my chair.  My body was having jerky movements (involuntary spasms), I had passed out,  my body temperature was rising, I lost control of my bladder also (it was basically all the manifestations of a seizure). The pharmacist panicked and have me an EPIPEN injection in my thigh (thinking I'm having an allergic reaction). They had also called 911 in the meanwhile. An ambulance arrived and took me to the ER. There they only did an ECG which was normal. They did not preform any blood tests and released me saying that it was "vasovagal syncope". However I spoke with a few family doctors to get opinions and multiple told me that is all signs of a seizure & not syncope. The ER doctor did tell me to make a follow up general checkup appointment with a PCP which I did a couple of weeks later.  The PCP requested a full blood palette test which came out normal.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Skin discolouration
Clinical narrative: I was perfectly healthy when I arrived at the pharmacy with my wife. I recieved my Pfizer covid shot and sat down on the chair in the observation waiting area. I felt a light tingling sensation in my arm (in which I got the shot)  but didn't think much of it (as I assumed the vaccine is stored at sub zero temperature). I started using my phone while waiting for my wife to get her shot next.  About 5 mins has elapsed,  that I fell off my chair.  My wife was there and panicked. As described to me by wife (who observed me first hand)  my face turned green as I fell face down from my chair.  My body was having jerky movements (involuntary spasms), I had passed out,  my body temperature was rising, I lost control of my bladder also (it was basically all the manifestations of a seizure). The pharmacist panicked and have me an EPIPEN injection in my thigh (thinking I'm having an allergic reaction). They had also called 911 in the meanwhile. An ambulance arrived and took me to the ER. There they only did an ECG which was normal. They did not preform any blood tests and released me saying that it was "vasovagal syncope". However I spoke with a few family doctors to get opinions and multiple told me that is all signs of a seizure & not syncope. The ER doctor did tell me to make a follow up general checkup appointment with a PCP which I did a couple of weeks later.  The PCP requested a full blood palette test which came out normal.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Body temperature increased, Dyskinesia, Electrocardiogram normal, Fall
Clinical narrative: I was perfectly healthy when I arrived at the pharmacy with my wife. I recieved my Pfizer covid shot and sat down on the chair in the observation waiting area. I felt a light tingling sensation in my arm (in which I got the shot)  but didn't think much of it (as I assumed the vaccine is stored at sub zero temperature). I started using my phone while waiting for my wife to get her shot next.  About 5 mins has elapsed,  that I fell off my chair.  My wife was there and panicked. As described to me by wife (who observed me first hand)  my face turned green as I fell face down from my chair.  My body was having jerky movements (involuntary spasms), I had passed out,  my body temperature was rising, I lost control of my bladder also (it was basically all the manifestations of a seizure). The pharmacist panicked and have me an EPIPEN injection in my thigh (thinking I'm having an allergic reaction). They had also called 911 in the meanwhile. An ambulance arrived and took me to the ER. There they only did an ECG which was normal. They did not preform any blood tests and released me saying that it was "vasovagal syncope". However I spoke with a few family doctors to get opinions and multiple told me that is all signs of a seizure & not syncope. The ER doctor did tell me to make a follow up general checkup appointment with a PCP which I did a couple of weeks later.  The PCP requested a full blood palette test which came out normal.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle spasms, Paraesthesia, Seizure, Skin discolouration, Urinary incontinence
Clinical narrative: I was perfectly healthy when I arrived at the pharmacy with my wife. I recieved my Pfizer covid shot and sat down on the chair in the observation waiting area. I felt a light tingling sensation in my arm (in which I got the shot)  but didn't think much of it (as I assumed the vaccine is stored at sub zero temperature). I started using my phone while waiting for my wife to get her shot next.  About 5 mins has elapsed,  that I fell off my chair.  My wife was there and panicked. As described to me by wife (who observed me first hand)  my face turned green as I fell face down from my chair.  My body was having jerky movements (involuntary spasms), I had passed out,  my body temperature was rising, I lost control of my bladder also (it was basically all the manifestations of a seizure). The pharmacist panicked and have me an EPIPEN injection in my thigh (thinking I'm having an allergic reaction). They had also called 911 in the meanwhile. An ambulance arrived and took me to the ER. There they only did an ECG which was normal. They did not preform any blood tests and released me saying that it was "vasovagal syncope". However I spoke with a few family doctors to get opinions and multiple told me that is all signs of a seizure & not syncope. The ER doctor did tell me to make a follow up general checkup appointment with a PCP which I did a couple of weeks later.  The PCP requested a full blood palette test which came out normal.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: Patient suffered with GBS as a result of the Pfizer vaccine - Seven days after vaccine, patient developed paresthesia in bilat feet. As the days went on, patient noted more paresthesia in bilat feet and fingers. Patient followed up with PCP and was given steroids.  The next day, patient noted voice changes. Patient went to ER  and shortly after getting to ER, patient could not move his arms, legs and then he required intubation. Patient was in ICU for over 2 weeks and then in rehab for a total of 3 weeks. Patient was released on 6/20/2021, trach and peg tube removed shortly thereafter.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Endotracheal intubation, Feeding tube user, Guillain-Barre syndrome, Intensive care
Clinical narrative: Patient suffered with GBS as a result of the Pfizer vaccine - Seven days after vaccine, patient developed paresthesia in bilat feet. As the days went on, patient noted more paresthesia in bilat feet and fingers. Patient followed up with PCP and was given steroids.  The next day, patient noted voice changes. Patient went to ER  and shortly after getting to ER, patient could not move his arms, legs and then he required intubation. Patient was in ICU for over 2 weeks and then in rehab for a total of 3 weeks. Patient was released on 6/20/2021, trach and peg tube removed shortly thereafter.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Paraesthesia, Tracheostomy tube removal
Clinical narrative: Patient suffered with GBS as a result of the Pfizer vaccine - Seven days after vaccine, patient developed paresthesia in bilat feet. As the days went on, patient noted more paresthesia in bilat feet and fingers. Patient followed up with PCP and was given steroids.  The next day, patient noted voice changes. Patient went to ER  and shortly after getting to ER, patient could not move his arms, legs and then he required intubation. Patient was in ICU for over 2 weeks and then in rehab for a total of 3 weeks. Patient was released on 6/20/2021, trach and peg tube removed shortly thereafter.
Age: 53.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Diplopia, Dizziness, Eye pain, Fatigue
Clinical narrative: Bilateral arms and face parenthesia and pain, sort like complex regional pain syndrome; later stroke like symptoms on 7/15/2021
Age: 53.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Feeling abnormal, Headache, Hypoaesthesia, Hypoaesthesia oral, Hypoaesthesia teeth
Clinical narrative: Bilateral arms and face parenthesia and pain, sort like complex regional pain syndrome; later stroke like symptoms on 7/15/2021
Age: 53.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Oscillopsia, Pain, Paraesthesia, Sleep disorder, Vision blurred
Clinical narrative: Bilateral arms and face parenthesia and pain, sort like complex regional pain syndrome; later stroke like symptoms on 7/15/2021
Age: 53.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Visual impairment
Clinical narrative: Bilateral arms and face parenthesia and pain, sort like complex regional pain syndrome; later stroke like symptoms on 7/15/2021
Age: 53.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Facial pain, Laboratory test, Neurological symptom, Pain in extremity, Paraesthesia
Clinical narrative: Bilateral arms and face parenthesia and pain, sort like complex regional pain syndrome; later stroke like symptoms on 7/15/2021
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pruritus, Throat tightness
Clinical narrative: Patient received 1st dose Pfizer on 8/27/21.  Ten minutes after vaccination, the patient developed a feeling of throat closing, full body itching, and hives.  The patient was given IM epinephrine and 50mg diphenhydramine, then transported to ED.  On arrival to ED, Temp=98.1F, HR=96, RR=18, BP=159/88, Sp02=100.  The patient on arrival did not appear in acute distress, no rash, lungs clear.  Patient did develop headache in ED.  Patient was monitored and treated with IV fluids, migraine therapy, decadron.  Patient discharged home on prednisone taper. On 8/31/21, patient contacted PCP with ongoing symptoms of shortness of breath, pain in throat, 'tightness on her chest.' Seen by provider on 9/3/21.  Lung exam clear, no evidence or respiratory distress.  Throat pain likely due to oropharyngeal candidiasis (likely driven by high amounts of systemic steroids).  Will refer to allergist for covid vaccine assessment.  9/7/21, patient contacted clinic to report 'brain fog, mouth numbing, no taste, headache.'  PCP suspected headache due to vaccine allergic reaction.  Prescribed oxycodone and seroquel since patient has not been able to sleep.  On 9/21/21, the patient saw PCP and reports dizziness, headache, and decreased concentration.  Ordered head CT (pending results)
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Chest discomfort, Computerised tomogram head, Disturbance in attention, Dizziness
Clinical narrative: Patient received 1st dose Pfizer on 8/27/21.  Ten minutes after vaccination, the patient developed a feeling of throat closing, full body itching, and hives.  The patient was given IM epinephrine and 50mg diphenhydramine, then transported to ED.  On arrival to ED, Temp=98.1F, HR=96, RR=18, BP=159/88, Sp02=100.  The patient on arrival did not appear in acute distress, no rash, lungs clear.  Patient did develop headache in ED.  Patient was monitored and treated with IV fluids, migraine therapy, decadron.  Patient discharged home on prednisone taper. On 8/31/21, patient contacted PCP with ongoing symptoms of shortness of breath, pain in throat, 'tightness on her chest.' Seen by provider on 9/3/21.  Lung exam clear, no evidence or respiratory distress.  Throat pain likely due to oropharyngeal candidiasis (likely driven by high amounts of systemic steroids).  Will refer to allergist for covid vaccine assessment.  9/7/21, patient contacted clinic to report 'brain fog, mouth numbing, no taste, headache.'  PCP suspected headache due to vaccine allergic reaction.  Prescribed oxycodone and seroquel since patient has not been able to sleep.  On 9/21/21, the patient saw PCP and reports dizziness, headache, and decreased concentration.  Ordered head CT (pending results)
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Feeling abnormal, Headache, Hypersensitivity, Hypoaesthesia oral
Clinical narrative: Patient received 1st dose Pfizer on 8/27/21.  Ten minutes after vaccination, the patient developed a feeling of throat closing, full body itching, and hives.  The patient was given IM epinephrine and 50mg diphenhydramine, then transported to ED.  On arrival to ED, Temp=98.1F, HR=96, RR=18, BP=159/88, Sp02=100.  The patient on arrival did not appear in acute distress, no rash, lungs clear.  Patient did develop headache in ED.  Patient was monitored and treated with IV fluids, migraine therapy, decadron.  Patient discharged home on prednisone taper. On 8/31/21, patient contacted PCP with ongoing symptoms of shortness of breath, pain in throat, 'tightness on her chest.' Seen by provider on 9/3/21.  Lung exam clear, no evidence or respiratory distress.  Throat pain likely due to oropharyngeal candidiasis (likely driven by high amounts of systemic steroids).  Will refer to allergist for covid vaccine assessment.  9/7/21, patient contacted clinic to report 'brain fog, mouth numbing, no taste, headache.'  PCP suspected headache due to vaccine allergic reaction.  Prescribed oxycodone and seroquel since patient has not been able to sleep.  On 9/21/21, the patient saw PCP and reports dizziness, headache, and decreased concentration.  Ordered head CT (pending results)
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Oropharyngeal candidiasis, Oropharyngeal pain, Pruritus, Throat tightness
Clinical narrative: Patient received 1st dose Pfizer on 8/27/21.  Ten minutes after vaccination, the patient developed a feeling of throat closing, full body itching, and hives.  The patient was given IM epinephrine and 50mg diphenhydramine, then transported to ED.  On arrival to ED, Temp=98.1F, HR=96, RR=18, BP=159/88, Sp02=100.  The patient on arrival did not appear in acute distress, no rash, lungs clear.  Patient did develop headache in ED.  Patient was monitored and treated with IV fluids, migraine therapy, decadron.  Patient discharged home on prednisone taper. On 8/31/21, patient contacted PCP with ongoing symptoms of shortness of breath, pain in throat, 'tightness on her chest.' Seen by provider on 9/3/21.  Lung exam clear, no evidence or respiratory distress.  Throat pain likely due to oropharyngeal candidiasis (likely driven by high amounts of systemic steroids).  Will refer to allergist for covid vaccine assessment.  9/7/21, patient contacted clinic to report 'brain fog, mouth numbing, no taste, headache.'  PCP suspected headache due to vaccine allergic reaction.  Prescribed oxycodone and seroquel since patient has not been able to sleep.  On 9/21/21, the patient saw PCP and reports dizziness, headache, and decreased concentration.  Ordered head CT (pending results)
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Patient received 1st dose Pfizer on 8/27/21.  Ten minutes after vaccination, the patient developed a feeling of throat closing, full body itching, and hives.  The patient was given IM epinephrine and 50mg diphenhydramine, then transported to ED.  On arrival to ED, Temp=98.1F, HR=96, RR=18, BP=159/88, Sp02=100.  The patient on arrival did not appear in acute distress, no rash, lungs clear.  Patient did develop headache in ED.  Patient was monitored and treated with IV fluids, migraine therapy, decadron.  Patient discharged home on prednisone taper. On 8/31/21, patient contacted PCP with ongoing symptoms of shortness of breath, pain in throat, 'tightness on her chest.' Seen by provider on 9/3/21.  Lung exam clear, no evidence or respiratory distress.  Throat pain likely due to oropharyngeal candidiasis (likely driven by high amounts of systemic steroids).  Will refer to allergist for covid vaccine assessment.  9/7/21, patient contacted clinic to report 'brain fog, mouth numbing, no taste, headache.'  PCP suspected headache due to vaccine allergic reaction.  Prescribed oxycodone and seroquel since patient has not been able to sleep.  On 9/21/21, the patient saw PCP and reports dizziness, headache, and decreased concentration.  Ordered head CT (pending results)
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Amnesia, COVID-19, Disorientation, Hypoxia, Mental status changes
Clinical narrative: 88 YO M admitted s/p MVA; pt found by EMS with only one shoe, half-buttoned shirt and disoriented. Pt reports hx of Alzheimers although normally "very functional". Pt reports some mild nausea, but no other sxns consistent with COVID. O2 on room air on admit (9/5) = 94%. Routine testing in ED + for COVID 19. Patient developed hypoxia (O2 = 88% on 9/6) overnight and started on txn for COVID.  S/p txn wtih steroids, remdesivir and oxygen.   Confusion and agitation continued throughout hospitalization - family requested patient transition to palliative care. Pt died 9/14
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Road traffic accident, SARS-CoV-2 test positive
Clinical narrative: 88 YO M admitted s/p MVA; pt found by EMS with only one shoe, half-buttoned shirt and disoriented. Pt reports hx of Alzheimers although normally "very functional". Pt reports some mild nausea, but no other sxns consistent with COVID. O2 on room air on admit (9/5) = 94%. Routine testing in ED + for COVID 19. Patient developed hypoxia (O2 = 88% on 9/6) overnight and started on txn for COVID.  S/p txn wtih steroids, remdesivir and oxygen.   Confusion and agitation continued throughout hospitalization - family requested patient transition to palliative care. Pt died 9/14
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Agitation, COVID-19, Confusional state, Death, Disorientation
Clinical narrative: 88 YO M admitted s/p MVA; pt found by EMS with only one shoe, half-buttoned shirt and disoriented. Pt reports hx of Alzheimers although normally "very functional". Pt reports some mild nausea, but no other sxns consistent with COVID. O2 on room air on admit (9/5) = 94%. Routine testing in ED + for COVID 19. Patient developed hypoxia (O2 = 88% on 9/6) overnight and started on txn for COVID.  S/p txn wtih steroids, remdesivir and oxygen.   Confusion and agitation continued throughout hospitalization - family requested patient transition to palliative care. Pt died 9/14
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Nausea, Oxygen saturation decreased, Road traffic accident, SARS-CoV-2 test positive
Clinical narrative: 88 YO M admitted s/p MVA; pt found by EMS with only one shoe, half-buttoned shirt and disoriented. Pt reports hx of Alzheimers although normally "very functional". Pt reports some mild nausea, but no other sxns consistent with COVID. O2 on room air on admit (9/5) = 94%. Routine testing in ED + for COVID 19. Patient developed hypoxia (O2 = 88% on 9/6) overnight and started on txn for COVID.  S/p txn wtih steroids, remdesivir and oxygen.   Confusion and agitation continued throughout hospitalization - family requested patient transition to palliative care. Pt died 9/14
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anion gap increased, Blood creatinine normal, Blood culture, Blood lactic acid, Blood potassium increased
Clinical narrative: Hospitalized 9/5 and died 9/24/2021
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood sodium decreased, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Hospitalized 9/5 and died 9/24/2021
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Dyspnoea, Exposure to SARS-CoV-2, Haemoglobin normal, Hypoxia
Clinical narrative: Hospitalized 9/5 and died 9/24/2021
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Liver function test normal, Lung opacity, Platelet count normal, Procalcitonin
Clinical narrative: Hospitalized 9/5 and died 9/24/2021
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: Hospitalized 9/5 and died 9/24/2021
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Hospitalized 9/5 and died 9/24/2021
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aspiration, Asthenia, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: ***ADDENDUM:  Pt previously reported to VAERS under ID #641016.  Adding information. Pt died on 9/26/2021    Hospital Course: PT is a 84 y.o. male with history of CAD (s/p CABG x 4), HTN, pancytopenia, and PUD who was admitted on 9/4 after presenting with hypoxia in the context of recently diagnosed COVID-19 infection.  He completed vaccination in March, developed symptoms of COVID 8/26, was diagnosed 8/29, and was admitted to the hospital on 9/4.  He was started on dexamethasone and remdesivir.  His O2 needs rapidly increased after admission and he had a marked elevation of his CRP to 15.6, prompting administration of tociluzimab.   He was treated for a possible concurrent bacterial pneumonia with 5 days of cefepime and 3 days of azithro with last dose of antbx on 9/13.  Diuresis was also attempted on several occasions in an attempt to improve his very poor oxygenation.  Despite these measures his resp failure progressed to point that PT was transferred to the ICU and required maximal noninvasive resp support with HFNC and BiPAP.  BiPAP was poorly tolerated.  He ultimately decided to be DNR but stabilized to an extent and was transferred back to HVU where he continued to require HFNC w/ FiO2 80-100% for many days.   On the evening of 9/24 his respiratory status worsened.  BiPAP was again attempted but he was not able to tolerate it.  A family meeting was held on 9/25 with discussions regarding end-of-life.  On the morning of 9/26 he had worsening respiratory status and indicated that he wanted transition to comfort care measures.  His family members were at the bedside when he passed away.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Decreased appetite, Infection, Intensive care, Lung opacity, Oxygen saturation decreased
Clinical narrative: ***ADDENDUM:  Pt previously reported to VAERS under ID #641016.  Adding information. Pt died on 9/26/2021    Hospital Course: PT is a 84 y.o. male with history of CAD (s/p CABG x 4), HTN, pancytopenia, and PUD who was admitted on 9/4 after presenting with hypoxia in the context of recently diagnosed COVID-19 infection.  He completed vaccination in March, developed symptoms of COVID 8/26, was diagnosed 8/29, and was admitted to the hospital on 9/4.  He was started on dexamethasone and remdesivir.  His O2 needs rapidly increased after admission and he had a marked elevation of his CRP to 15.6, prompting administration of tociluzimab.   He was treated for a possible concurrent bacterial pneumonia with 5 days of cefepime and 3 days of azithro with last dose of antbx on 9/13.  Diuresis was also attempted on several occasions in an attempt to improve his very poor oxygenation.  Despite these measures his resp failure progressed to point that PT was transferred to the ICU and required maximal noninvasive resp support with HFNC and BiPAP.  BiPAP was poorly tolerated.  He ultimately decided to be DNR but stabilized to an extent and was transferred back to HVU where he continued to require HFNC w/ FiO2 80-100% for many days.   On the evening of 9/24 his respiratory status worsened.  BiPAP was again attempted but he was not able to tolerate it.  A family meeting was held on 9/25 with discussions regarding end-of-life.  On the morning of 9/26 he had worsening respiratory status and indicated that he wanted transition to comfort care measures.  His family members were at the bedside when he passed away.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: ***ADDENDUM:  Pt previously reported to VAERS under ID #641016.  Adding information. Pt died on 9/26/2021    Hospital Course: PT is a 84 y.o. male with history of CAD (s/p CABG x 4), HTN, pancytopenia, and PUD who was admitted on 9/4 after presenting with hypoxia in the context of recently diagnosed COVID-19 infection.  He completed vaccination in March, developed symptoms of COVID 8/26, was diagnosed 8/29, and was admitted to the hospital on 9/4.  He was started on dexamethasone and remdesivir.  His O2 needs rapidly increased after admission and he had a marked elevation of his CRP to 15.6, prompting administration of tociluzimab.   He was treated for a possible concurrent bacterial pneumonia with 5 days of cefepime and 3 days of azithro with last dose of antbx on 9/13.  Diuresis was also attempted on several occasions in an attempt to improve his very poor oxygenation.  Despite these measures his resp failure progressed to point that PT was transferred to the ICU and required maximal noninvasive resp support with HFNC and BiPAP.  BiPAP was poorly tolerated.  He ultimately decided to be DNR but stabilized to an extent and was transferred back to HVU where he continued to require HFNC w/ FiO2 80-100% for many days.   On the evening of 9/24 his respiratory status worsened.  BiPAP was again attempted but he was not able to tolerate it.  A family meeting was held on 9/25 with discussions regarding end-of-life.  On the morning of 9/26 he had worsening respiratory status and indicated that he wanted transition to comfort care measures.  His family members were at the bedside when he passed away.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, Death, Hypoxia, Intensive care
Clinical narrative: ***ADDENDUM:  Pt previously reported to VAERS under ID #641016.  Adding information. Pt died on 9/26/2021    Hospital Course: PT is a 84 y.o. male with history of CAD (s/p CABG x 4), HTN, pancytopenia, and PUD who was admitted on 9/4 after presenting with hypoxia in the context of recently diagnosed COVID-19 infection.  He completed vaccination in March, developed symptoms of COVID 8/26, was diagnosed 8/29, and was admitted to the hospital on 9/4.  He was started on dexamethasone and remdesivir.  His O2 needs rapidly increased after admission and he had a marked elevation of his CRP to 15.6, prompting administration of tociluzimab.   He was treated for a possible concurrent bacterial pneumonia with 5 days of cefepime and 3 days of azithro with last dose of antbx on 9/13.  Diuresis was also attempted on several occasions in an attempt to improve his very poor oxygenation.  Despite these measures his resp failure progressed to point that PT was transferred to the ICU and required maximal noninvasive resp support with HFNC and BiPAP.  BiPAP was poorly tolerated.  He ultimately decided to be DNR but stabilized to an extent and was transferred back to HVU where he continued to require HFNC w/ FiO2 80-100% for many days.   On the evening of 9/24 his respiratory status worsened.  BiPAP was again attempted but he was not able to tolerate it.  A family meeting was held on 9/25 with discussions regarding end-of-life.  On the morning of 9/26 he had worsening respiratory status and indicated that he wanted transition to comfort care measures.  His family members were at the bedside when he passed away.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Oxygen saturation decreased, Polyuria, Positive airway pressure therapy, Respiratory failure
Clinical narrative: ***ADDENDUM:  Pt previously reported to VAERS under ID #641016.  Adding information. Pt died on 9/26/2021    Hospital Course: PT is a 84 y.o. male with history of CAD (s/p CABG x 4), HTN, pancytopenia, and PUD who was admitted on 9/4 after presenting with hypoxia in the context of recently diagnosed COVID-19 infection.  He completed vaccination in March, developed symptoms of COVID 8/26, was diagnosed 8/29, and was admitted to the hospital on 9/4.  He was started on dexamethasone and remdesivir.  His O2 needs rapidly increased after admission and he had a marked elevation of his CRP to 15.6, prompting administration of tociluzimab.   He was treated for a possible concurrent bacterial pneumonia with 5 days of cefepime and 3 days of azithro with last dose of antbx on 9/13.  Diuresis was also attempted on several occasions in an attempt to improve his very poor oxygenation.  Despite these measures his resp failure progressed to point that PT was transferred to the ICU and required maximal noninvasive resp support with HFNC and BiPAP.  BiPAP was poorly tolerated.  He ultimately decided to be DNR but stabilized to an extent and was transferred back to HVU where he continued to require HFNC w/ FiO2 80-100% for many days.   On the evening of 9/24 his respiratory status worsened.  BiPAP was again attempted but he was not able to tolerate it.  A family meeting was held on 9/25 with discussions regarding end-of-life.  On the morning of 9/26 he had worsening respiratory status and indicated that he wanted transition to comfort care measures.  His family members were at the bedside when he passed away.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient seen in ED with N/V (chronic problem - multiple ED visits for epigastric pain, abdominal pain, n/v) and abdominal pain - took 2 trazodone prior to admission and "passed out". Seen in ED; assessed as anxious, benign abdominal exam; labs and CT scan unremarkable during ED visit the day prior for the same. Pt was planning to be d/c and stated that "she was going to kill herself"; pt admitted with 72 hr hold for suicide. During routine testing found to be COVID +. No symptoms consistent with COVID - appears to be incidental finding.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Anxiety, COVID-19, Computerised tomogram normal
Clinical narrative: Patient seen in ED with N/V (chronic problem - multiple ED visits for epigastric pain, abdominal pain, n/v) and abdominal pain - took 2 trazodone prior to admission and "passed out". Seen in ED; assessed as anxious, benign abdominal exam; labs and CT scan unremarkable during ED visit the day prior for the same. Pt was planning to be d/c and stated that "she was going to kill herself"; pt admitted with 72 hr hold for suicide. During routine testing found to be COVID +. No symptoms consistent with COVID - appears to be incidental finding.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test normal, SARS-CoV-2 test positive, Suicidal ideation
Clinical narrative: Patient seen in ED with N/V (chronic problem - multiple ED visits for epigastric pain, abdominal pain, n/v) and abdominal pain - took 2 trazodone prior to admission and "passed out". Seen in ED; assessed as anxious, benign abdominal exam; labs and CT scan unremarkable during ED visit the day prior for the same. Pt was planning to be d/c and stated that "she was going to kill herself"; pt admitted with 72 hr hold for suicide. During routine testing found to be COVID +. No symptoms consistent with COVID - appears to be incidental finding.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest discomfort, Chest pain, Dyspnoea, Echocardiogram
Clinical narrative: Patient received first dose on 8/23/21. Patient reports shortly after she started having shortness of breath and pain down the side of her neck and under breast bone. On 8/28 patient finally went to urgent care. They sent her immediately to ER and was diagnosed with mycocarditis and and enlarged heart.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Feeling abnormal, Myocarditis, Physical examination, X-ray
Clinical narrative: Patient received first dose on 8/23/21. Patient reports shortly after she started having shortness of breath and pain down the side of her neck and under breast bone. On 8/28 patient finally went to urgent care. They sent her immediately to ER and was diagnosed with mycocarditis and and enlarged heart.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test abnormal, Cardiac dysfunction, Cardiomegaly, Chest pain, Dyspnoea
Clinical narrative: Patient received first dose on 8/23/21. Patient reports shortly after she started having shortness of breath and pain down the side of her neck and under breast bone. On 8/28 patient finally went to urgent care. They sent her immediately to ER and was diagnosed with mycocarditis and and enlarged heart.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Myocarditis, Neck pain, X-ray abnormal
Clinical narrative: Patient received first dose on 8/23/21. Patient reports shortly after she started having shortness of breath and pain down the side of her neck and under breast bone. On 8/28 patient finally went to urgent care. They sent her immediately to ER and was diagnosed with mycocarditis and and enlarged heart.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Injection site pain
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Catheterisation cardiac, Chest pain, Dyspnoea, Echocardiogram
Clinical narrative: The patient received the first dose of the Moderna COVID vaccine on 08/20/2021 and the second dose on 09/17/2021. Around 0830 on 09/19/2021 the patient started experiencing left-sided chest pain that radiated down into his left shoulder and back along with shortness of breath. The pain was intermittent but worsened around 20:00 when sitting down. The patient was transferred to a level 2 trauma center from a critical access hospital, and was taken straight to the cath lab upon arriving at the trauma 2 for presumed STEMI. In the cath lab they found an ejection fraction of 50% with normal coronary arteries. He was admitted for myocarditis with mild acute systolic and diastolic CHF with an ejection fraction of 45-50%.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ST segment elevation, Magnetic resonance imaging heart, Myocardial infarction, Myocarditis, Troponin increased
Clinical narrative: The patient received the first dose of the Moderna COVID vaccine on 08/20/2021 and the second dose on 09/17/2021. Around 0830 on 09/19/2021 the patient started experiencing left-sided chest pain that radiated down into his left shoulder and back along with shortness of breath. The pain was intermittent but worsened around 20:00 when sitting down. The patient was transferred to a level 2 trauma center from a critical access hospital, and was taken straight to the cath lab upon arriving at the trauma 2 for presumed STEMI. In the cath lab they found an ejection fraction of 50% with normal coronary arteries. He was admitted for myocarditis with mild acute systolic and diastolic CHF with an ejection fraction of 45-50%.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute left ventricular failure, Acute myocardial infarction, Arthralgia, Back pain, Chest pain
Clinical narrative: The patient received the first dose of the Moderna COVID vaccine on 08/20/2021 and the second dose on 09/17/2021. Around 0830 on 09/19/2021 the patient started experiencing left-sided chest pain that radiated down into his left shoulder and back along with shortness of breath. The pain was intermittent but worsened around 20:00 when sitting down. The patient was transferred to a level 2 trauma center from a critical access hospital, and was taken straight to the cath lab upon arriving at the trauma 2 for presumed STEMI. In the cath lab they found an ejection fraction of 50% with normal coronary arteries. He was admitted for myocarditis with mild acute systolic and diastolic CHF with an ejection fraction of 45-50%.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram ST segment elevation, Electrocardiogram abnormal
Clinical narrative: The patient received the first dose of the Moderna COVID vaccine on 08/20/2021 and the second dose on 09/17/2021. Around 0830 on 09/19/2021 the patient started experiencing left-sided chest pain that radiated down into his left shoulder and back along with shortness of breath. The pain was intermittent but worsened around 20:00 when sitting down. The patient was transferred to a level 2 trauma center from a critical access hospital, and was taken straight to the cath lab upon arriving at the trauma 2 for presumed STEMI. In the cath lab they found an ejection fraction of 50% with normal coronary arteries. He was admitted for myocarditis with mild acute systolic and diastolic CHF with an ejection fraction of 45-50%.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test abnormal, Left ventricular end-diastolic pressure increased, Myocarditis, Pain, Sinus bradycardia
Clinical narrative: The patient received the first dose of the Moderna COVID vaccine on 08/20/2021 and the second dose on 09/17/2021. Around 0830 on 09/19/2021 the patient started experiencing left-sided chest pain that radiated down into his left shoulder and back along with shortness of breath. The pain was intermittent but worsened around 20:00 when sitting down. The patient was transferred to a level 2 trauma center from a critical access hospital, and was taken straight to the cath lab upon arriving at the trauma 2 for presumed STEMI. In the cath lab they found an ejection fraction of 50% with normal coronary arteries. He was admitted for myocarditis with mild acute systolic and diastolic CHF with an ejection fraction of 45-50%.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Echocardiogram abnormal, Headache
Clinical narrative: The patient reports that he had COVID-19 in January, 2021 had uncomplicated course and on Friday receive the 2nd in his series of Pfizer vaccine.  The patient reports that he tolerated the 1st vaccine injection quite well had no difficulty except for localized reaction in the arm.  The patient reports with the 2nd dose he developed fever, body aches, chest pain, shortness of breath.  The patient reports that the chest pain did not come on to this morning the patient states he woke at 7:30 a.m. after staying up late and developed pain in the lower sternum and retrosternal space.  The patient has no cough congestion runny nose no ongoing fevers has some mild body aches.  The patient has no known history of thromboembolic disease is no family history of thromboembolic disease.  The patient has no increased work of breathing hypoxemia and has not had a fever last 24 hours he currently rates his pain at a 2/10 is not take any Tylenol ibuprofen prior to arrival.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Left ventricular dysfunction, Malaise, Pyrexia, Sinus arrhythmia, Troponin increased
Clinical narrative: The patient reports that he had COVID-19 in January, 2021 had uncomplicated course and on Friday receive the 2nd in his series of Pfizer vaccine.  The patient reports that he tolerated the 1st vaccine injection quite well had no difficulty except for localized reaction in the arm.  The patient reports with the 2nd dose he developed fever, body aches, chest pain, shortness of breath.  The patient reports that the chest pain did not come on to this morning the patient states he woke at 7:30 a.m. after staying up late and developed pain in the lower sternum and retrosternal space.  The patient has no cough congestion runny nose no ongoing fevers has some mild body aches.  The patient has no known history of thromboembolic disease is no family history of thromboembolic disease.  The patient has no increased work of breathing hypoxemia and has not had a fever last 24 hours he currently rates his pain at a 2/10 is not take any Tylenol ibuprofen prior to arrival.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Echocardiogram normal, Fibrin D dimer normal
Clinical narrative: The patient reports that he had COVID-19 in January, 2021 had uncomplicated course and on Friday receive the 2nd in his series of Pfizer vaccine.  The patient reports that he tolerated the 1st vaccine injection quite well had no difficulty except for localized reaction in the arm.  The patient reports with the 2nd dose he developed fever, body aches, chest pain, shortness of breath.  The patient reports that the chest pain did not come on to this morning the patient states he woke at 7:30 a.m. after staying up late and developed pain in the lower sternum and retrosternal space.  The patient has no cough congestion runny nose no ongoing fevers has some mild body aches.  The patient has no known history of thromboembolic disease is no family history of thromboembolic disease.  The patient has no increased work of breathing hypoxemia and has not had a fever last 24 hours he currently rates his pain at a 2/10 is not take any Tylenol ibuprofen prior to arrival.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Myocarditis, Palpitations, Pyrexia, Troponin increased
Clinical narrative: The patient reports that he had COVID-19 in January, 2021 had uncomplicated course and on Friday receive the 2nd in his series of Pfizer vaccine.  The patient reports that he tolerated the 1st vaccine injection quite well had no difficulty except for localized reaction in the arm.  The patient reports with the 2nd dose he developed fever, body aches, chest pain, shortness of breath.  The patient reports that the chest pain did not come on to this morning the patient states he woke at 7:30 a.m. after staying up late and developed pain in the lower sternum and retrosternal space.  The patient has no cough congestion runny nose no ongoing fevers has some mild body aches.  The patient has no known history of thromboembolic disease is no family history of thromboembolic disease.  The patient has no increased work of breathing hypoxemia and has not had a fever last 24 hours he currently rates his pain at a 2/10 is not take any Tylenol ibuprofen prior to arrival.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Pain, Pyrexia, Troponin
Clinical narrative: The patient reports that he had COVID-19 in January, 2021 had uncomplicated course and on Friday receive the 2nd in his series of Pfizer vaccine.  The patient reports that he tolerated the 1st vaccine injection quite well had no difficulty except for localized reaction in the arm.  The patient reports with the 2nd dose he developed fever, body aches, chest pain, shortness of breath.  The patient reports that the chest pain did not come on to this morning the patient states he woke at 7:30 a.m. after staying up late and developed pain in the lower sternum and retrosternal space.  The patient has no cough congestion runny nose no ongoing fevers has some mild body aches.  The patient has no known history of thromboembolic disease is no family history of thromboembolic disease.  The patient has no increased work of breathing hypoxemia and has not had a fever last 24 hours he currently rates his pain at a 2/10 is not take any Tylenol ibuprofen prior to arrival.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Computerised tomogram, Full blood count, Magnetic resonance imaging
Clinical narrative: Adverse Event: Right side of face drooped, headache, ear pain. Treatment: Emergency room visit at Hospital Outcome: Diagnosed with Bell's Palsy
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Computerised tomogram, Ear pain, Facial paralysis, Headache
Clinical narrative: Adverse Event: Right side of face drooped, headache, ear pain. Treatment: Emergency room visit at Hospital Outcome: Diagnosed with Bell's Palsy
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging
Clinical narrative: Adverse Event: Right side of face drooped, headache, ear pain. Treatment: Emergency room visit at Hospital Outcome: Diagnosed with Bell's Palsy
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Muscle tightness, Neck pain
Clinical narrative: DIFFICULT TO LIFT WITH AFFECTED ARM; PAIN IN UPPER ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1816027 expiry: UNKNOWN) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-SEP-2021, the patient experienced difficult to lift with affected arm. On 23-SEP-2021, the patient experienced pain in upper arm. Treatment medications (dates unspecified) included: caffeine/paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in upper arm, and the outcome of difficult to lift with affected arm was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Hypokinesia, Pain in extremity
Clinical narrative: DIFFICULT TO LIFT WITH AFFECTED ARM; PAIN IN UPPER ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1816027 expiry: UNKNOWN) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-SEP-2021, the patient experienced difficult to lift with affected arm. On 23-SEP-2021, the patient experienced pain in upper arm. Treatment medications (dates unspecified) included: caffeine/paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in upper arm, and the outcome of difficult to lift with affected arm was not reported. This report was non-serious.